Apuli Maricel sold BBIO
February 16, 2026 · Form 4 insider transaction
Apuli Maricel sold 4,349 shares of BridgeBio Pharma, Inc. at $75.25 per share, a transaction worth $327.3K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,349
Price
$75.25
Total value
$327.3K
InsiderApuli Maricel
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 16, 2026
Filing dateFebruary 18, 2026
Shares owned after124,455
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligation in connection with the vesting of 8,377 shares of Common Stock underlying the Reporting Person's RSUs.; Includes 510 shares of the Issuer's Common Stock acquired by the Reporting Person on February 13, 2026 pursuant to the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.